Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hemogenyx Pharmaceuticals Plc.
(OP:
HOPHF
)
0.0031
UNCHANGED
Last Price
Updated: 12:21 PM EDT, Aug 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Hemogenyx Pharmaceuticals Plc.
< Previous
1
2
3
Next >
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director’s Dealing
May 08, 2025
Via
ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Second Patient Treated with HG-CT-1 CAR-T Therapy
May 02, 2025
Via
ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Final Results
April 28, 2025
Via
ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report
April 03, 2025
Via
ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
March 31, 2025
Via
ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
March 11, 2025
Via
ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Opening of First Clinical Site
December 30, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Ultrafast CAR-T Manufacturing
December 19, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces First Patient Safety
March 24, 2025
Via
ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials
March 17, 2025
Via
ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces First-in-Human Treatment with HG-CT-1
February 24, 2025
Via
ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes
February 19, 2025
Via
ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Admission of New Ordinary Shares and New ISIN
December 10, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Site Initiation Visit Completed
December 09, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces CBR Macrophage Delivery Update
December 06, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting
November 22, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces IRB Approval for Phase I Clinical Trial
November 22, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
November 10, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Strategic Investment from Prevail Partners, LLC
October 02, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Half-year Report
September 26, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC - FLT3 Assay Ready for Phase I Trials at MD Anderson
September 08, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces CDX Development Update
September 01, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Presentation at CBD S&T Conference
August 27, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Macrophage-Directed Therapies Summit Presentation
July 28, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Operations Update
June 16, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Result of Annual General Meeting
June 27, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Final Results
April 24, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
March 27, 2024
Via
ACCESSWIRE
Hemogenyx Pharmaceuticals discusses successful £3.5M capital raise as it advances HEMO-CAR-T program
March 12, 2024
Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) Dr Vladislav Sandler joins Proactive's Stephen Gunnion after the pre-clinical stage biopharmaceutical group raised £3.5 million, which will be...
Via
TheNewswire.com
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise US$4.2 million
February 28, 2024
Via
ACCESSWIRE
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
